DLH HOLDINGS CORP (DLHC) Stock Fundamental Analysis
NASDAQ:DLHC - Nasdaq - US23335Q1004 - Common Stock - Currency: USD
Taking everything into account, DLHC scores 3 out of 10 in our fundamental rating. DLHC was compared to 82 industry peers in the Professional Services industry. DLHC has a medium profitability rating, but doesn't score so well on its financial health evaluation. DLHC has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
DLHC had positive earnings in the past year.
DLHC had a positive operating cash flow in the past year.
Each year in the past 5 years DLHC has been profitable.
Each year in the past 5 years DLHC had a positive operating cash flow.
1.2 Ratios
DLHC has a Return On Assets (1.77%) which is in line with its industry peers.
With a Return On Equity value of 4.81%, DLHC perfoms like the industry average, outperforming 47.56% of the companies in the same industry.
DLHC's Return On Invested Capital of 7.05% is in line compared to the rest of the industry. DLHC outperforms 52.44% of its industry peers.
DLHC had an Average Return On Invested Capital over the past 3 years of 11.89%. This is in line with the industry average of 12.28%.
The last Return On Invested Capital (7.05%) for DLHC is well below the 3 year average (11.89%), which needs to be investigated, but indicates that DLHC had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.77% | ||
| ROE | 4.81% | ||
| ROIC | 7.05% |
ROA(3y)5.52%
ROA(5y)5.11%
ROE(3y)11.15%
ROE(5y)12.44%
ROIC(3y)11.89%
ROIC(5y)11.02%
1.3 Margins
The Profit Margin of DLHC (1.44%) is comparable to the rest of the industry.
DLHC's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 6.07%, DLHC is in line with its industry, outperforming 58.54% of the companies in the same industry.
DLHC's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 19.80%, DLHC is doing worse than 75.61% of the companies in the same industry.
DLHC's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.07% | ||
| PM (TTM) | 1.44% | ||
| GM | 19.8% |
OM growth 3Y-5.45%
OM growth 5Y-2.42%
PM growth 3Y-23.19%
PM growth 5Y-10.78%
GM growth 3Y-1.6%
GM growth 5Y-2.24%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DLHC is creating some value.
The number of shares outstanding for DLHC has been increased compared to 1 year ago.
DLHC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DLHC has an improved debt to assets ratio.
2.2 Solvency
DLHC has an Altman-Z score of 1.80. This is a bad value and indicates that DLHC is not financially healthy and even has some risk of bankruptcy.
DLHC has a Altman-Z score of 1.80. This is in the lower half of the industry: DLHC underperforms 67.07% of its industry peers.
DLHC has a debt to FCF ratio of 7.49. This is a slightly negative value and a sign of low solvency as DLHC would need 7.49 years to pay back of all of its debts.
With a Debt to FCF ratio value of 7.49, DLHC perfoms like the industry average, outperforming 41.46% of the companies in the same industry.
A Debt/Equity ratio of 1.15 is on the high side and indicates that DLHC has dependencies on debt financing.
DLHC has a worse Debt to Equity ratio (1.15) than 75.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.15 | ||
| Debt/FCF | 7.49 | ||
| Altman-Z | 1.8 |
ROIC/WACC0.66
WACC10.61%
2.3 Liquidity
DLHC has a Current Ratio of 1.10. This is a normal value and indicates that DLHC is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of DLHC (1.10) is worse than 68.29% of its industry peers.
A Quick Ratio of 1.10 indicates that DLHC should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.10, DLHC is not doing good in the industry: 68.29% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.1 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
The earnings per share for DLHC have decreased strongly by -30.91% in the last year.
Measured over the past 5 years, DLHC shows a small growth in Earnings Per Share. The EPS has been growing by 1.22% on average per year.
DLHC shows a decrease in Revenue. In the last year, the revenue decreased by -6.34%.
The Revenue has been growing by 19.81% on average over the past years. This is quite good.
EPS 1Y (TTM)-30.91%
EPS 3Y-11.67%
EPS 5Y1.22%
EPS Q2Q%-50%
Revenue 1Y (TTM)-6.34%
Revenue growth 3Y17.18%
Revenue growth 5Y19.81%
Sales Q2Q%-11.68%
3.2 Future
DLHC is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -44.22% yearly.
DLHC is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -17.14% yearly.
EPS Next Y-62%
EPS Next 2Y-44.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.37%
Revenue Next 2Y-17.14%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
DLHC is valuated correctly with a Price/Earnings ratio of 14.92.
Based on the Price/Earnings ratio, DLHC is valued a bit cheaper than the industry average as 73.17% of the companies are valued more expensively.
DLHC is valuated rather cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
The Forward Price/Earnings Ratio is negative for DLHC. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.92 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DLHC indicates a rather cheap valuation: DLHC is cheaper than 93.90% of the companies listed in the same industry.
98.78% of the companies in the same industry are more expensive than DLHC, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.15 | ||
| EV/EBITDA | 5.7 |
4.3 Compensation for Growth
A cheap valuation may be justified as DLHC's earnings are expected to decrease with -44.22% in the coming years.
PEG (NY)N/A
PEG (5Y)12.23
EPS Next 2Y-44.22%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for DLHC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:DLHC (7/14/2025, 3:36:44 PM)
5.67
+0.03 (+0.53%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners70.95%
Inst Owner Change0%
Ins Owners13.55%
Ins Owner Change0%
Market Cap81.59M
Analysts82.86
Price Target10.2 (79.89%)
Short Float %2.42%
Short Ratio3.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.96%
Min EPS beat(2)-15.97%
Max EPS beat(2)12.04%
EPS beat(4)2
Avg EPS beat(4)-1.32%
Min EPS beat(4)-43.98%
Max EPS beat(4)42.6%
EPS beat(8)5
Avg EPS beat(8)5.76%
EPS beat(12)7
Avg EPS beat(12)4.24%
EPS beat(16)9
Avg EPS beat(16)2.55%
Revenue beat(2)0
Avg Revenue beat(2)-5.53%
Min Revenue beat(2)-8.25%
Max Revenue beat(2)-2.82%
Revenue beat(4)0
Avg Revenue beat(4)-5.41%
Min Revenue beat(4)-8.25%
Max Revenue beat(4)-2.82%
Revenue beat(8)1
Avg Revenue beat(8)-3.97%
Revenue beat(12)1
Avg Revenue beat(12)-4.25%
Revenue beat(16)3
Avg Revenue beat(16)-2.85%
PT rev (1m)0%
PT rev (3m)-33.33%
EPS NQ rev (1m)-50%
EPS NQ rev (3m)118.18%
EPS NY rev (1m)246.15%
EPS NY rev (3m)246.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)12.16%
Revenue NY rev (1m)8.17%
Revenue NY rev (3m)8.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.92 | ||
| Fwd PE | N/A | ||
| P/S | 0.22 | ||
| P/FCF | 4.15 | ||
| P/OCF | 4.07 | ||
| P/B | 0.72 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.7 |
EPS(TTM)0.38
EY6.7%
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)1.37
FCFY24.09%
OCF(TTM)1.39
OCFY24.55%
SpS26.2
BVpS7.84
TBVpS-8.71
PEG (NY)N/A
PEG (5Y)12.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.77% | ||
| ROE | 4.81% | ||
| ROCE | 8.92% | ||
| ROIC | 7.05% | ||
| ROICexc | 7.05% | ||
| ROICexgc | 99.15% | ||
| OM | 6.07% | ||
| PM (TTM) | 1.44% | ||
| GM | 19.8% | ||
| FCFM | 5.21% |
ROA(3y)5.52%
ROA(5y)5.11%
ROE(3y)11.15%
ROE(5y)12.44%
ROIC(3y)11.89%
ROIC(5y)11.02%
ROICexc(3y)11.91%
ROICexc(5y)11.55%
ROICexgc(3y)142.07%
ROICexgc(5y)N/A
ROCE(3y)15.05%
ROCE(5y)13.95%
ROICexcg growth 3YN/A
ROICexcg growth 5Y-9.4%
ROICexc growth 3Y-17.74%
ROICexc growth 5Y-3.87%
OM growth 3Y-5.45%
OM growth 5Y-2.42%
PM growth 3Y-23.19%
PM growth 5Y-10.78%
GM growth 3Y-1.6%
GM growth 5Y-2.24%
F-Score7
Asset Turnover1.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.15 | ||
| Debt/FCF | 7.49 | ||
| Debt/EBITDA | 3.26 | ||
| Cap/Depr | 2.17% | ||
| Cap/Sales | 0.1% | ||
| Interest Coverage | 1.49 | ||
| Cash Conversion | 50.05% | ||
| Profit Quality | 362.24% | ||
| Current Ratio | 1.1 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 1.8 |
F-Score7
WACC10.61%
ROIC/WACC0.66
Cap/Depr(3y)6.77%
Cap/Depr(5y)4.74%
Cap/Sales(3y)0.2%
Cap/Sales(5y)0.14%
Profit Quality(3y)813.86%
Profit Quality(5y)632.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.91%
EPS 3Y-11.67%
EPS 5Y1.22%
EPS Q2Q%-50%
EPS Next Y-62%
EPS Next 2Y-44.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.34%
Revenue growth 3Y17.18%
Revenue growth 5Y19.81%
Sales Q2Q%-11.68%
Revenue Next Year-13.37%
Revenue Next 2Y-17.14%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.39%
EBIT growth 3Y10.79%
EBIT growth 5Y16.91%
EBIT Next Year31.23%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-9.3%
FCF growth 3Y-16.5%
FCF growth 5Y8.52%
OCF growth 1Y-12.61%
OCF growth 3Y-15.69%
OCF growth 5Y8.69%